Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02874274 · ClinicalTrials.gov registry record · NA
Vaccination Uptake (VAX) in PD
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 164
- Enrollment target
NCT02874274 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 164 participants.
The verdict
NCT02874274, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 164 participants
- Enrollment target
Study Summary
This is a study to see whether participation in the Edmond J. Safra Interdisciplinary Home Visit Program for Advanced Parkinson's (HVP) increases the rate of age-appropriate vaccinations in people with advanced Parkinson's Disease (PD) and related disorders. This study will evaluate the impact of the HVP on the rate of common illnesses such as flu and pneumonia in patients with advanced PD and related disorders over the course of one year. As there is currently no data available on the baseline rate of vaccinations in either homebound or less disabled PD populations, investigators will seek to establish the baseline rate of vaccinations, barriers to getting vaccinated, and baseline healthcare utilization in these populations by piloting (Phase 1) and then implementing (Phase 2) a survey via telephone interviews. Investigators will then test feasibility of offering influenza and pneumococcal vaccinations, as appropriate, to the homebound individuals in our HVP cohort (Phase 3), and will compare their pre- and post-intervention rates of both outpatient and acute healthcare utilization and self-reported illness.
Interventions
- BEHAVIORAL Standard of Care
- BEHAVIORAL Home Visit Program (HVP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2016-09 |
| Est. Completion | 2018-04-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02874274
The ClinicalTrials.gov registry entry for NCT02874274 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 164 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT02874274 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02874274 about?
NCT02874274 is a clinical study titled "Vaccination Uptake (VAX) in PD". This is a study to see whether participation in the Edmond J. Safra Interdisciplinary Home Visit Program for Advanced Parkinson's (HVP) increases the rate of age-appropriate vaccinations in people with advanced Parkinson's Disease (PD) and related disorders. This study will evaluate the impact of th...
What is the current status of trial NCT02874274?
This trial is currently completed. It is a NA study. The enrollment target is 164 participants. The study started on 2016-09. Estimated completion is 2018-04-12.
What interventions are being tested in trial NCT02874274?
The interventions under investigation include: Standard of Care (BEHAVIORAL), Home Visit Program (HVP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02874274?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.